Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

Similar articles for PubMed (Select 17002487)

1.
2.

Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus.

Fullerton B, Jeitler K, Seitz M, Horvath K, Berghold A, Siebenhofer A.

Cochrane Database Syst Rev. 2014 Feb 14;2:CD009122. doi: 10.1002/14651858.CD009122.pub2. Review.

PMID:
24526393
3.

Issues surrounding tight glycemic control in people with type 2 diabetes mellitus.

Cerveny JD, Leder RD, Weart CW.

Ann Pharmacother. 1998 Sep;32(9):896-905. Review.

PMID:
9762378
4.

Intensive glucose control in the management of diabetes mellitus and inpatient hyperglycemia.

Shogbon AO, Levy SB.

Am J Health Syst Pharm. 2010 May 15;67(10):798-805. doi: 10.2146/ajhp090211. Review.

PMID:
20479101
5.

Care of adults with type 2 diabetes mellitus. A review of the evidence.

O'Connor PJ, Spann SJ, Woolf SH.

J Fam Pract. 1998 Nov;47(5 Suppl):S13-22. Review.

PMID:
9834750
6.
7.

Diabetes and peripheral vascular disease.

Huysman E, Mathieu C.

Acta Chir Belg. 2009 Oct;109(5):587-94. Review.

PMID:
19994800
8.

[Treatment of diabetes in metabolic syndrome].

Pelikánova T.

Vnitr Lek. 2009 Jul-Aug;55(7-8):637-45. Review. Czech.

PMID:
19731868
9.

Prevention of the complications of diabetes.

Vinik AI, Vinik E.

Am J Manag Care. 2003 Mar;9(3 Suppl):S63-80; quiz S81-4. Review.

10.

Pharmacologic prevention of microvascular and macrovascular complications in diabetes mellitus: implications of the results of recent clinical trials in type 2 diabetes.

Tandon N, Ali MK, Narayan KM.

Am J Cardiovasc Drugs. 2012 Feb 1;12(1):7-22. doi: 10.2165/11594650-000000000-00000. Review.

PMID:
22217193
11.

Postprandial hyperglycemia and endothelial function in type 2 diabetes: focus on mitiglinide.

Kitasato L, Tojo T, Hatakeyama Y, Kameda R, Hashikata T, Yamaoka-Tojo M.

Cardiovasc Diabetol. 2012 Jun 29;11:79. doi: 10.1186/1475-2840-11-79. Review.

12.

Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.

Kuzuya T, Nakagawa S, Satoh J, Kanazawa Y, Iwamoto Y, Kobayashi M, Nanjo K, Sasaki A, Seino Y, Ito C, Shima K, Nonaka K, Kadowaki T; Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus.

Diabetes Res Clin Pract. 2002 Jan;55(1):65-85.

PMID:
11755481
13.

The association between intensive glycemic control and vascular complications in type 2 diabetes mellitus: a meta-analysis.

Ma J, Yang W, Fang N, Zhu W, Wei M.

Nutr Metab Cardiovasc Dis. 2009 Nov;19(9):596-603. doi: 10.1016/j.numecd.2009.07.004. Epub 2009 Oct 9.

PMID:
19819121
14.

Oral antidiabetic agents: current role in type 2 diabetes mellitus.

Krentz AJ, Bailey CJ.

Drugs. 2005;65(3):385-411. Review.

PMID:
15669880
15.

Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes.

Dailey G.

Clin Ther. 2011 Jun;33(6):665-78. doi: 10.1016/j.clinthera.2011.04.025. Review.

PMID:
21704233
16.

Therapeutic potential of aleglitazar, a new dual PPAR-α/γ agonist: implications for cardiovascular disease in patients with diabetes mellitus.

Cavender MA, Lincoff AM.

Am J Cardiovasc Drugs. 2010;10(4):209-16. doi: 10.2165/11539500-000000000-00000.

PMID:
20653327
17.
18.

Glycemic control and complications in type 2 diabetes mellitus.

Stolar M.

Am J Med. 2010 Mar;123(3 Suppl):S3-11. doi: 10.1016/j.amjmed.2009.12.004. Review.

PMID:
20206730
19.

Intensive glycemic control and cardiovascular disease: an update.

Brown A, Reynolds LR, Bruemmer D.

Nat Rev Cardiol. 2010 Jul;7(7):369-75. doi: 10.1038/nrcardio.2010.35. Epub 2010 Apr 20. Review.

PMID:
20404853
20.

Glycemic control in the prevention of diabetic complications.

Ratner RE.

Clin Cornerstone. 2001;4(2):24-37. Review.

PMID:
11838325
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk